Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
gentamicinsulfat 0,3 % øjensalve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 0,1 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 60 mg/100 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 100 mg/100 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 60 mg/50 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Gentamicin sulfate 80mg/50mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 100 mg/50 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 3 mg/g salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 0,1 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 1 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 40 mg/100 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 40 mg/100 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 0,8 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 0,8 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 1,2 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 1,2 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Gentamicin sulfate 1.6mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 1,6 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 120 mg/100 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 120 mg/100 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Gentamicin sulfate 2.4mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 2,4 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 80 mg/100 ml infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 80 mg/100 ml infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicin 0,3 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicin 0,3 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Product containing precisely gentamicin (as gentamicin sulfate) 15 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicin 1,5 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicin 0,3 % øjen-/øredråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfatpræparat til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Gentamicin 0.3% eye drops 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Gentamicin 0.3% eye drops 10mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Gentamicin 0.3% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat 0,3 % wt/wt + prednisolonacetat 0,6 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat + prednisolonacetat 0,3 %/1 % vol/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicinsulfat + prednisolonacetat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamicin 0,3 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Gentamicin 0.3% eye drops 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Gentamicin 0.3% eye drops 10mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
gentamycinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
|
Product containing precisely gentamicin (as gentamicin sulfate) 15 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
gentamicin 0,3 % øjen-/øredråber |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
2 |
Product containing precisely gentamicin (as gentamicin sulfate) 80 milligram/2 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 20 milligram/2 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 40 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 80 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
gentamicinsulfat 0,3 % opløsning til oftalmisk anvendelse |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
gentamicinsulfat 0,3 % opløsning til oftalmisk anvendelse |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 900 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Gentamicin (as gentamicin sulfate) 1 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Gentamicin (as gentamicin sulfate) 3 mg/g eye ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Gentamicin (as gentamicin sulfate) 1 mg/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely clobetasol propionate 500 microgram/1 gram and gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
2 |
Gentamicin (as gentamicin sulfate) 3 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |
Product containing precisely gentamicin (as gentamicin sulfate) 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Gentamicin sulfate |
Inferred relationship |
Some |
1 |